SCL Science Statistics
Total Valuation
SCL Science has a market cap or net worth of KRW 83.06 billion. The enterprise value is 96.29 billion.
Market Cap | 83.06B |
Enterprise Value | 96.29B |
Important Dates
The last earnings date was Tuesday, August 12, 2025.
Earnings Date | Aug 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SCL Science has 33.97 million shares outstanding. The number of shares has increased by 9.29% in one year.
Current Share Class | 33.97M |
Shares Outstanding | 33.97M |
Shares Change (YoY) | +9.29% |
Shares Change (QoQ) | -0.01% |
Owned by Insiders (%) | 5.74% |
Owned by Institutions (%) | n/a |
Float | 14.04M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 8.87 |
PB Ratio | 3.21 |
P/TBV Ratio | 5.91 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -27.22 |
EV / Sales | 10.29 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -13.06 |
Financial Position
The company has a current ratio of 2.23, with a Debt / Equity ratio of 0.93.
Current Ratio | 2.23 |
Quick Ratio | 1.76 |
Debt / Equity | 0.93 |
Debt / EBITDA | n/a |
Debt / FCF | -3.27 |
Interest Coverage | -5.72 |
Financial Efficiency
Return on equity (ROE) is -16.22% and return on invested capital (ROIC) is -8.42%.
Return on Equity (ROE) | -16.22% |
Return on Assets (ROA) | -7.27% |
Return on Invested Capital (ROIC) | -8.42% |
Return on Capital Employed (ROCE) | -10.12% |
Revenue Per Employee | 150.96M |
Profits Per Employee | -57.06M |
Employee Count | 62 |
Asset Turnover | 0.22 |
Inventory Turnover | 7.69 |
Taxes
Income Tax | -16.57M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.83% in the last 52 weeks. The beta is 0.92, so SCL Science's price volatility has been similar to the market average.
Beta (5Y) | 0.92 |
52-Week Price Change | +5.83% |
50-Day Moving Average | 2,827.70 |
200-Day Moving Average | 2,316.85 |
Relative Strength Index (RSI) | 40.72 |
Average Volume (20 Days) | 73,794 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SCL Science had revenue of KRW 9.36 billion and -3.54 billion in losses. Loss per share was -120.44.
Revenue | 9.36B |
Gross Profit | 1.47B |
Operating Income | -4.87B |
Pretax Income | -3.55B |
Net Income | -3.54B |
EBITDA | -3.05B |
EBIT | -4.87B |
Loss Per Share | -120.44 |
Balance Sheet
The company has 10.93 billion in cash and 24.14 billion in debt, giving a net cash position of -13.21 billion or -388.87 per share.
Cash & Cash Equivalents | 10.93B |
Total Debt | 24.14B |
Net Cash | -13.21B |
Net Cash Per Share | -388.87 |
Equity (Book Value) | 25.90B |
Book Value Per Share | 761.98 |
Working Capital | 13.57B |
Cash Flow
In the last 12 months, operating cash flow was -6.97 billion and capital expenditures -405.38 million, giving a free cash flow of -7.37 billion.
Operating Cash Flow | -6.97B |
Capital Expenditures | -405.38M |
Free Cash Flow | -7.37B |
FCF Per Share | -217.00 |
Margins
Gross margin is 15.66%, with operating and profit margins of -51.98% and -37.80%.
Gross Margin | 15.66% |
Operating Margin | -51.98% |
Pretax Margin | -37.98% |
Profit Margin | -37.80% |
EBITDA Margin | -32.63% |
EBIT Margin | -51.98% |
FCF Margin | n/a |
Dividends & Yields
SCL Science does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -9.29% |
Shareholder Yield | n/a |
Earnings Yield | -4.26% |
FCF Yield | -8.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on June 30, 2025. It was a forward split with a ratio of 4.
Last Split Date | Jun 30, 2025 |
Split Type | Forward |
Split Ratio | 4 |
Scores
SCL Science has an Altman Z-Score of 0.4 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.4 |
Piotroski F-Score | 1 |